- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/70 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Patent holdings for IPC class C07D 333/70
Total number of patents in this class: 155
10-year publication summary
|
8
|
9
|
11
|
10
|
6
|
14
|
15
|
6
|
9
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Eonhf, Inc. | 45 |
7 |
| VALO Health, Inc. | 193 |
6 |
| Ctxt Pty Ltd | 62 |
5 |
| Astellas Pharma Inc. | 1039 |
4 |
| University of Kansas | 924 |
4 |
| C&C Research Laboratories | 18 |
4 |
| Accent Therapeutics, Inc. | 26 |
4 |
| Pfizer Inc. | 3409 |
3 |
| Curis, Inc. | 130 |
3 |
| Tokyo Ohka Kogyo Co., Ltd. | 1569 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3010 |
3 |
| Vanderbilt University | 2028 |
3 |
| Vivace Therapeutics, Inc. | 32 |
3 |
| Janssen Pharmaceutica N.V. | 3160 |
2 |
| Bayer AG | 3522 |
2 |
| Takeda Pharmaceutical Company Limited | 2700 |
2 |
| The Broad Institute, Inc. | 1986 |
2 |
| Chiesi Farmaceutici S.p.A. | 955 |
2 |
| Encysive Pharmaceuticals Inc. | 7 |
2 |
| Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 75 |
2 |
| Other owners | 89 |